Alumis Inc. SEC filings ALMS
Alumis Inc. has 248 filings in SEC EDGAR's recent list, going back to Feb 25, 2021. Its latest annual report, Form ARS, was filed on May 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 1, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 1, 2026 | Sep 1, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Other events
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 2, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Other events
|
Jun 29, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Other events
|
Mar 30, 2026 | Mar 28, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2026 | Mar 19, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 9, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Other events
|
Jan 6, 2026 | Jan 6, 2026 |
| 8-K |
Current report
Other events
|
Jan 2, 2026 | Jan 2, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Other events
|
Sep 3, 2025 | Sep 3, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Aug 4, 2025 | Jul 30, 2025 |
| 8-K/A | Amended current report | Jun 30, 2025 | May 21, 2025 |
| 8-K |
Current report
Acquisition or sale of assets, Officer or director change, Other events
|
May 21, 2025 | May 21, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2025 | May 13, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 21, 2025 | Apr 20, 2025 |
| 8-K |
Current report
Other events
|
Mar 25, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2025 | Mar 19, 2025 |
| 8-K |
Current report
Other events
|
Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Other events
|
Mar 10, 2025 | Mar 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2025 | Mar 4, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 21, 2025 | Feb 18, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure, Other events
|
Feb 6, 2025 | Feb 6, 2025 |
| 8-K |
Current report
Other events
|
Nov 25, 2024 | Nov 22, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Other events
|
Jul 18, 2024 | Jul 17, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 3, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 1, 2024 | Jul 1, 2024 |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ALMS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1847367
- Former names
- FL2021-001, Inc. (until Mar 19, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.